cannabinoid CB2 agonists (Novasite)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namecannabinoid CB2 agonists (Novasite)
Drug Alias Namecannabinoid CB2 agonists (Novosite)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB2 receptor agonists
TargetsCannabinoid CB2 receptor
Therapy Area/IndicationsImmune System DiseasesNeuralgiaBrain Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovasite Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovasite Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsImmune System DiseasesNeuralgiaBrain Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A